Condensed Consolidated Statements of Equity (Unaudited) - USD ($)	Boyalife Investment Fund II, Inc. [Member] Common Stock [Member]	Boyalife Investment Fund II, Inc. [Member] Additional Paid-in Capital [Member]	Boyalife Investment Fund II, Inc. [Member] Retained Earnings [Member]	Boyalife Investment Fund II, Inc. [Member] AOCI Attributable to Parent [Member]	[1]	Boyalife Investment Fund II, Inc. [Member] Noncontrolling Interest [Member]	Boyalife Investment Fund II, Inc. [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]		Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2018								2,168,337
Balance at Dec. 31, 2018								$ 2,000	$ 235,888,000	$ (227,435,000)	$ (13,000)	[1]	$ (1,711,000)	$ 6,731,000
Stock-based compensation expense									81,000			[1]		81,000
Exercise of pre-funded warrants (in shares)								50,000
Exercise of pre-funded warrants									5,000			[1]		5,000
Discount due to beneficial conversion features									1,513,000			[1]		1,513,000
Foreign currency translation gain (loss)											(4,000)			(4,000)
Net loss										(1,871,000)		[1]	(176,000)	(2,047,000)
Reorganization of subsidiary and related change in non-controlling interest									(2,843,000)				2,843,000
Balance (in shares) at Mar. 31, 2019								2,218,337
Balance at Mar. 31, 2019								$ 2,000	234,644,000	(229,306,000)	(17,000)	[1]	956,000	6,279,000
Balance (in shares) at Dec. 31, 2018								2,168,337
Balance at Dec. 31, 2018								$ 2,000	235,888,000	(227,435,000)	(13,000)	[1]	(1,711,000)	6,731,000
Foreign currency translation gain (loss)														(7,000)
Balance (in shares) at Jun. 30, 2019								2,368,337
Balance at Jun. 30, 2019								$ 2,000	236,343,000	(230,603,000)	(20,000)	[1]	778,000	6,500,000
Balance (in shares) at Mar. 31, 2019								2,218,337
Balance at Mar. 31, 2019								$ 2,000	234,644,000	(229,306,000)	(17,000)	[1]	956,000	6,279,000
Stock-based compensation expense									125,000			[1]		125,000
Exercise of pre-funded warrants (in shares)								150,000
Exercise of pre-funded warrants									18,000			[1]		18,000
Discount due to beneficial conversion features									800,000			[1]		800,000
Issuance of common stock, net									756,000					756,000
Foreign currency translation gain (loss)											(3,000)			(3,000)
Net loss										(1,297,000)		[1]	(178,000)	(1,475,000)
Balance (in shares) at Jun. 30, 2019								2,368,337
Balance at Jun. 30, 2019								$ 2,000	236,343,000	(230,603,000)	(20,000)	[1]	778,000	6,500,000
Balance (in shares) at Dec. 31, 2019								2,843,601
Balance at Dec. 31, 2019								$ 3,000	237,313,000	(236,932,000)	2,000	[1]	530,000	916,000
Stock-based compensation expense									67,000			[1]		67,000
Exercise of pre-funded warrants (in shares)								100,000
Exercise of pre-funded warrants									10,000			[1]		10,000
Exercise of warrants (in shares)								7,866
Exercise of warrants									47,000			[1]		47,000
Discount due to beneficial conversion features									1,869,000			[1]		1,869,000
Conversion of note payable to common stock (in shares)	1,666,670							100,000
Conversion of note payable to common stock	$ 2,000	$ 2,998,000					$ 3,000,000		180,000			[1]		180,000
Issuance of common stock, net (in shares)								1,050,748
Issuance of common stock, net								$ 1,000	3,220,000					3,221,000
Foreign currency translation gain (loss)											38,000	[1]		38,000
Net loss										(4,602,000)		[1]	(141,000)	(4,743,000)
Balance (in shares) at Mar. 31, 2020								5,768,885
Balance at Mar. 31, 2020								$ 6,000	245,704,000	(241,534,000)	40,000	[1]	389,000	4,605,000
Balance (in shares) at Dec. 31, 2019								2,843,601
Balance at Dec. 31, 2019								$ 3,000	237,313,000	(236,932,000)	2,000	[1]	530,000	916,000
Foreign currency translation gain (loss)														39,000
Balance (in shares) at Jun. 30, 2020								6,709,465
Balance at Jun. 30, 2020								$ 7,000	252,937,000	(247,971,000)	41,000	[1]	316,000	5,330,000
Balance (in shares) at Mar. 31, 2020								5,768,885
Balance at Mar. 31, 2020								$ 6,000	245,704,000	(241,534,000)	40,000	[1]	389,000	4,605,000
Stock-based compensation expense									314,000			[1]		314,000
Exercise of pre-funded warrants (in shares)								224,445
Exercise of pre-funded warrants									22,000			[1]		22,000
Exercise of warrants (in shares)								267,271
Exercise of warrants									1,604,000					1,604,000
Discount due to beneficial conversion features									3,112,000			[1]		3,112,000
Conversion of note payable to common stock (in shares)								104,445
Conversion of note payable to common stock								$ 1,000	188,000					189,000
Issuance of common stock, net (in shares)								344,419
Issuance of common stock, net									1,993,000					1,993,000
Foreign currency translation gain (loss)											1,000			1,000
Net loss										(6,437,000)		[1]	(73,000)	(6,510,000)
Balance (in shares) at Jun. 30, 2020								6,709,465
Balance at Jun. 30, 2020								$ 7,000	$ 252,937,000	$ (247,971,000)	$ 41,000	[1]	$ 316,000	$ 5,330,000

[1] Accumulated other comprehensive loss.